Every workout floods your bloodstream with stem cells — your body’s own repair crew. Learn how exercise mobilizes regenerative cells and why it matters for aging and healing.
The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.
A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.
Your body’s stem cell population drops dramatically after 40. Here’s what the science says about why we age — and how regenerative medicine is fighting back.
A technical review of 3D bioprinting for cartilage repair: thiolated bioinks, scaffold optimization, MSC chondrogenesis, and the path to clinical translation.
Learn how MSC therapy is offering real hope for liver cirrhosis patients — with data from the latest 2026 clinical trials and real patient outcomes at our Bangkok clinic.
Analyse technique approfondie de l'immunomodulation par les CSM pour les maladies auto-immunes : induction des Treg, polarisation des macrophages et données cliniques issues de l'essai SMART-MS.
French 
English 
Chinese 
Russian